{"ticker": {"uuid": "cccafb96-da26-4ee2-9d57-c993dcfec8e9", "symbol": "002422", "name": "Sichuan Kelun Pharmaceutical Co., Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Sichuan Kelun Pharmaceutical Receives AAA Rating From China's Lianhe Credit; Shares Slide 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOd0RSazQwa2t5dzh0YUdwZWJGZmU2R1U2WF90VHNWNFhINTc0VFVmZ2NtY1NHUEZ6WVVxV2JZRXIzakkxbE5SemNVbll0VEl0djE1Um9jQ1FIWHpUdF9sdzMwV0JVWGM5UTdJbExKQlE1ckFHcVdBak1LcEIweHcyR1dMdGExWGE1TlB2ZkNSUWp0S2FuUmZDU2dBLXdSTkZXNksyV3dUTHJkYUF0aFZn?oc=5", "source_name": "Moomoo", "published_at": "2026-07-17T05:53:05+00:00", "published_display": "17 Jul 2026 05:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chinese pharmaceutical companies are transitioning from 'product internationalization' to 'industrial globalization,' highlighting investment opportunities in the CXO sector.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxOek5Za2hPejRMUENocV92X24yOGt0T0pNUFJVRklUNjNjNTBvN0FKVzlPd3U3Z0VfT25vTzlSMzJJM0U0RjZYamRhQUdWM282TFpxck8wQ3I0T1Z5alB4a29HZU1qQXdKOGJmQVFGS2JxM0pzVU15S1dMbFdya2lPWVZnS1VsdXBnWE5YeHpjZ2NOWWhNcERMalFvdURzcTFrSFJ3cFlvcS1scV9qZWtlam1DSlR6TmIzYlQ1dXpKc1QxZjFsbUU4eDQ1bkdYRlBNbmVyVXZiRHlodw?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-12T23:42:02+00:00", "published_display": "12 Jul 2026 23:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kelun Pharma Cites No New Report to Justify 20% Stock Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQMGVpRl8zb3ExbzlDU0pTZWRnNEZPT0FVbUpEa3ZKS190cVJqRFFRYU8wYmhJamNpbjFxdGZXaDZTV25lT0lMazNEZmExTHJFck5zUWpHRFl2NXhpUWd5T29FREJDcW41ZkotaS1HU1dkWEJfeXZDYXZOSC04aTNDdWVjNnZYdXJZV0J4SEk0SFBONXRKLWtZMG5n?oc=5", "source_name": "Moomoo", "published_at": "2026-07-06T07:12:07+00:00", "published_display": "06 Jul 2026 07:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPcEltaEwtVll0Yzl0RkpRWmJBcFkyUWc0OU5NY3NfS2l2VS1hbnYxdUltX1I1LTlGTGpnOVRPVWdPdkJSZFNzU21FRzR1ZUstY05MX3Z3MmRKOUxjOHNKS0xsX1pkZ3dmWDhHbXJJQUYzVGJha3plbEdXRVVZV1FmOGI4a1BBWXZ5WlROek1qeUdMaDBFOFpvVmRIb1RmUG1GMXc?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Merck discontinues some cancer drug development with China's Sichuan Kelun", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPMVV5S2E2MGxiMWN1V1N4RnhVdFJmUlUzbHE2b3duQXRmcHJtdU1uX0cyVURtREE3bUMtYXAzY3d3NnZoUnNQeTF2dEx5blcyMjRTc0RkSWhZSHpiNVFhV01tRExiSUJKV1hDRm1tSTNONFNZS2ZYY3VvWWFVb2dVSVJ3ajFDdzhzY19SZ0RDQTByeTdrM3pGWDNRN0RJeVo2ck42aHFMZUQtZUstb2NnMjExLTl4OFdydUx6NllFbEV0Vml1dHRIN2FMRm1udTBnaGFzT0EzSHUwV29pQ1E?oc=5", "source_name": "Reuters", "published_at": "2023-10-23T07:00:00+00:00", "published_display": "23 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sichuan Kelun-Biotech Opens Books For $208 Million Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNMjdwLWZ1cVptV3F0cGVOcXdjdmprZE00QjFRR2txaDhoTk14V3hlVVdvQVB5SVhKZHlQcWtma3JRUjBMWHhqMXdvQUpkMEZiSnVGaUV0T0hnS2RGQmMtM1ZpSlNVN0JsQ1hiYmZleVFaMUpxUmJjWW9fS0FCa21qSE1Oa29DWWVzeU1sMDc4eEJxX0dtUGdDMUxTNFNpelhEc2t3a0wyb2owSlp4NnJ0VXV2TzdOYk0?oc=5", "source_name": "CEO Insights Asia", "published_at": "2023-06-28T07:00:00+00:00", "published_display": "28 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Merck puts eye-popping $9.3B on the line in lopsided ADC deal with Kelun-Biotech", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNYi02RTNJd18yQ2pMZ2pLUzVPeTJSYVM2TXIxaU5FX1QwLVZBa3MwWTd5ZmF3dmNZNkRiSjdUR2Z1ZDNMRDJFSmE2OFZRUmhLUGstNGRORVFicDlBZlh1ek1pdkNVWmZ1ay1SbTNtUVNvci1SZUd6ckpaWGQza056YlRiWllmRGhPV1Z3N0c0bmJnUWlqeVUyMWRkUkxfRFpRcUFhQk42N2dFZGxwSnlpQmNUSUN0WlplazZj?oc=5", "source_name": "Fierce Biotech", "published_at": "2022-12-22T08:00:00+00:00", "published_display": "22 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwJBVV95cUxQT29kRVh3MHBFWk1mNjYxS1UxUWtCank2NTdBRWVDTkZMX0JWYVdqWnBaejRLUV9jSExQTnNCQVBqTjZkbFF3UWZ0d0F6bHVLWDB5Z3ZZcEZuYk9ZUU5aZEJFSzYyWXZOVko0c0hLZnFJVHdvNzZEcnRDMk1raEduczltWGllUG1ZODJTaHBCcjIyOFhFaEhnTE1ZMURTMWJjc3ZWVUxoVHRqaGw3bGJ5MHBRWk1qTjFkWGpqenJhU0QtNDg5bklob3M0YzBUSHdleFRyWVZpQzk3UHQ0aFR3czREWTE5Qm9MZjcwbElCWEVZS1pXOTRKbF9Yd1oteDQ1TjRxY2RURklEcUk4X3NjTXkyamo4dF9nNFdHZ2ZlWDRZRlFhU0JvLUJXOHJZYnlaWHdyZ1BUaXpKdXVVUnc1NzdoY3I5NjA?oc=5", "source_name": "Business Wire", "published_at": "2022-12-22T08:00:00+00:00", "published_display": "22 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Sichuan Kelun Pharmaceutical Receives AAA Rating From China's Lianhe Credit; Shares Slide 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOd0RSazQwa2t5dzh0YUdwZWJGZmU2R1U2WF90VHNWNFhINTc0VFVmZ2NtY1NHUEZ6WVVxV2JZRXIzakkxbE5SemNVbll0VEl0djE1Um9jQ1FIWHpUdF9sdzMwV0JVWGM5UTdJbExKQlE1ckFHcVdBak1LcEIweHcyR1dMdGExWGE1TlB2ZkNSUWp0S2FuUmZDU2dBLXdSTkZXNksyV3dUTHJkYUF0aFZn?oc=5", "source_name": "Moomoo", "published_at": "2026-07-17T05:53:05+00:00", "published_display": "17 Jul 2026 05:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chinese pharmaceutical companies are transitioning from 'product internationalization' to 'industrial globalization,' highlighting investment opportunities in the CXO sector.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxOek5Za2hPejRMUENocV92X24yOGt0T0pNUFJVRklUNjNjNTBvN0FKVzlPd3U3Z0VfT25vTzlSMzJJM0U0RjZYamRhQUdWM282TFpxck8wQ3I0T1Z5alB4a29HZU1qQXdKOGJmQVFGS2JxM0pzVU15S1dMbFdya2lPWVZnS1VsdXBnWE5YeHpjZ2NOWWhNcERMalFvdURzcTFrSFJ3cFlvcS1scV9qZWtlam1DSlR6TmIzYlQ1dXpKc1QxZjFsbUU4eDQ1bkdYRlBNbmVyVXZiRHlodw?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-12T23:42:02+00:00", "published_display": "12 Jul 2026 23:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kelun Pharma Cites No New Report to Justify 20% Stock Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQMGVpRl8zb3ExbzlDU0pTZWRnNEZPT0FVbUpEa3ZKS190cVJqRFFRYU8wYmhJamNpbjFxdGZXaDZTV25lT0lMazNEZmExTHJFck5zUWpHRFl2NXhpUWd5T29FREJDcW41ZkotaS1HU1dkWEJfeXZDYXZOSC04aTNDdWVjNnZYdXJZV0J4SEk0SFBONXRKLWtZMG5n?oc=5", "source_name": "Moomoo", "published_at": "2026-07-06T07:12:07+00:00", "published_display": "06 Jul 2026 07:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPcEltaEwtVll0Yzl0RkpRWmJBcFkyUWc0OU5NY3NfS2l2VS1hbnYxdUltX1I1LTlGTGpnOVRPVWdPdkJSZFNzU21FRzR1ZUstY05MX3Z3MmRKOUxjOHNKS0xsX1pkZ3dmWDhHbXJJQUYzVGJha3plbEdXRVVZV1FmOGI4a1BBWXZ5WlROek1qeUdMaDBFOFpvVmRIb1RmUG1GMXc?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Merck discontinues some cancer drug development with China's Sichuan Kelun", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPMVV5S2E2MGxiMWN1V1N4RnhVdFJmUlUzbHE2b3duQXRmcHJtdU1uX0cyVURtREE3bUMtYXAzY3d3NnZoUnNQeTF2dEx5blcyMjRTc0RkSWhZSHpiNVFhV01tRExiSUJKV1hDRm1tSTNONFNZS2ZYY3VvWWFVb2dVSVJ3ajFDdzhzY19SZ0RDQTByeTdrM3pGWDNRN0RJeVo2ck42aHFMZUQtZUstb2NnMjExLTl4OFdydUx6NllFbEV0Vml1dHRIN2FMRm1udTBnaGFzT0EzSHUwV29pQ1E?oc=5", "source_name": "Reuters", "published_at": "2023-10-23T07:00:00+00:00", "published_display": "23 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sichuan Kelun-Biotech Opens Books For $208 Million Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNMjdwLWZ1cVptV3F0cGVOcXdjdmprZE00QjFRR2txaDhoTk14V3hlVVdvQVB5SVhKZHlQcWtma3JRUjBMWHhqMXdvQUpkMEZiSnVGaUV0T0hnS2RGQmMtM1ZpSlNVN0JsQ1hiYmZleVFaMUpxUmJjWW9fS0FCa21qSE1Oa29DWWVzeU1sMDc4eEJxX0dtUGdDMUxTNFNpelhEc2t3a0wyb2owSlp4NnJ0VXV2TzdOYk0?oc=5", "source_name": "CEO Insights Asia", "published_at": "2023-06-28T07:00:00+00:00", "published_display": "28 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Merck puts eye-popping $9.3B on the line in lopsided ADC deal with Kelun-Biotech", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNYi02RTNJd18yQ2pMZ2pLUzVPeTJSYVM2TXIxaU5FX1QwLVZBa3MwWTd5ZmF3dmNZNkRiSjdUR2Z1ZDNMRDJFSmE2OFZRUmhLUGstNGRORVFicDlBZlh1ek1pdkNVWmZ1ay1SbTNtUVNvci1SZUd6ckpaWGQza056YlRiWllmRGhPV1Z3N0c0bmJnUWlqeVUyMWRkUkxfRFpRcUFhQk42N2dFZGxwSnlpQmNUSUN0WlplazZj?oc=5", "source_name": "Fierce Biotech", "published_at": "2022-12-22T08:00:00+00:00", "published_display": "22 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwJBVV95cUxQT29kRVh3MHBFWk1mNjYxS1UxUWtCank2NTdBRWVDTkZMX0JWYVdqWnBaejRLUV9jSExQTnNCQVBqTjZkbFF3UWZ0d0F6bHVLWDB5Z3ZZcEZuYk9ZUU5aZEJFSzYyWXZOVko0c0hLZnFJVHdvNzZEcnRDMk1raEduczltWGllUG1ZODJTaHBCcjIyOFhFaEhnTE1ZMURTMWJjc3ZWVUxoVHRqaGw3bGJ5MHBRWk1qTjFkWGpqenJhU0QtNDg5bklob3M0YzBUSHdleFRyWVZpQzk3UHQ0aFR3czREWTE5Qm9MZjcwbElCWEVZS1pXOTRKbF9Yd1oteDQ1TjRxY2RURklEcUk4X3NjTXkyamo4dF9nNFdHZ2ZlWDRZRlFhU0JvLUJXOHJZYnlaWHdyZ1BUaXpKdXVVUnc1NzdoY3I5NjA?oc=5", "source_name": "Business Wire", "published_at": "2022-12-22T08:00:00+00:00", "published_display": "22 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 58, "total_relevant": 8, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 8, "score": 50, "total": 8, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 74, "events": [{"event": "general", "label": "Market update", "weight": 2.55, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 44.91, "latest_week": "2026-07-17", "one_week_move": 1.9, "four_week_move": 25.0, "twelve_week_move": 34.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.343481, "market_dynamics_buy_signal": false, "relative_strength": 29.120366, "fair_value_gap": 45.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 40.1185, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.9% over one week, +25.0% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 56, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Moomoo", "count": 2}, {"label": "\u5bcc\u9014\u725b\u725b", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "CEO Insights Asia", "count": 1}, {"label": "Fierce Biotech", "count": 1}, {"label": "Business Wire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Analyst action", "count": 1}, {"label": "Earnings", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "74/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+1.9% over one week, +25.0% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Sichuan Kelun Pharmaceutical Receives AAA Rating From China's Lianhe Credit; Shares Slide 10%"}], "updated_at": "2026-07-21T23:37:28.481208+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}